- Details
- Description
-
Packaging Size1Bottle/Box
-
Strength100mg/10ml
-
CompositonZuberitamab
-
TreatmentDiffuse large B lymphoma,DLBCL
-
FormInjection
-
BrandAnruixi (安瑞昔)
-
Quantity Unit100mg(10ml)*1Bottle/Box
-
ManufacturerBioray Biopharmaceutical Co. Ltd., China
Zuberitamab is an innovative anti-CD20 monoclonal antibody injection. Zuberitamab is a biosimilar of rituximab, a monoclonal antibody which targets CD20.
- Zuberitamab sold under the brand name 安瑞昔(Anruixi )® in china.
This drug was approved by the Chinese National Medical Products Administration and was recently launched in diffuse large B lymphoma (https://www.nmpa.gov.cn/yaowen/ypjgyw/ypyw/20230517152922112).